Geneos Wealth Management’s Vanguard FTSE Emerging Markets ETF VWO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11M Buy
203,555
+37,229
+22% +$2.09M 0.26% 89
2025
Q4
$8.94M Buy
166,326
+11,845
+8% +$643K 0.22% 115
2025
Q3
$8.37M Sell
154,481
-116,688
-43% -$6.01M 0.21% 125
2025
Q2
$13.4M Sell
271,169
-102,114
-27% -$4.74M 0.33% 72
2025
Q1
$24.4M Buy
373,283
+239,018
+178% +$10.8M 0.35% 67
2024
Q4
$5.91M Sell
134,265
-6,603
-5% -$307K 0.21% 110
2024
Q3
$6.74M Buy
140,868
+7,800
+6% +$347K 0.26% 90
2024
Q2
$5.82M Buy
133,068
+6,789
+5% +$292K 0.26% 86
2024
Q1
$5.27M Sell
126,279
-3,305
-3% -$135K 0.24% 101
2023
Q4
$5.33M Sell
129,584
-2,001
-2% -$79.4K 0.26% 94
2023
Q3
$5.16M Buy
131,585
+25,746
+24% +$1.05M 0.27% 99
2023
Q2
$4.31M Buy
105,839
+28,785
+37% +$1.16M 0.23% 122
2023
Q1
$3.11M Buy
77,054
+40,367
+110% +$1.64M 0.19% 140
2022
Q4
$1.43M Sell
36,687
-2,835
-7% -$108K 0.09% 219
2022
Q3
$1.44M Sell
39,522
-3,150
-7% -$128K 0.1% 205
2022
Q2
$1.77M Buy
42,672
+2,109
+5% +$91.1K 0.09% 223
2022
Q1
$1.87M Sell
40,563
-4,978
-11% -$239K 0.08% 233
2021
Q4
$2.25M Buy
45,541
+17
+0% +$857 0.09% 238
2021
Q3
$2.28M Buy
45,524
+1,511
+3% +$78.1K 0.09% 225
2021
Q2
$2.37M Sell
44,013
-198,348
-82% -$10.6M 0.09% 211
2021
Q1
$12.8M Sell
242,361
-14,815
-6% -$789K 0.36% 67
2020
Q4
$2.08M Buy
257,176
+225,832
+720% +$10.6M 0.08% 229
2020
Q3
$1.32M Sell
31,344
-2,865
-8% -$125K 0.07% 251
2020
Q2
$1.35M Sell
34,209
-22,366
-40% -$828K 0.08% 241
2020
Q1
$1.86M Buy
56,575
+4,671
+9% +$190K 0.13% 174
2019
Q4
$2.31M Sell
51,904
-3,396
-6% -$144K 0.12% 183
2019
Q3
$2.22M Sell
55,300
-36,638
-40% -$1.51M 0.13% 171
2019
Q2
$3.91M Sell
91,938
-253
-0.3% -$10.6K 0.24% 108
2019
Q1
$3.92M Sell
92,191
-12,713
-12% -$523K 0.26% 106
2018
Q4
$4.03M Buy
104,904
+1,377
+1% +$53.3K 0.3% 88
2018
Q3
$4.24M Sell
103,527
-91,658
-47% -$3.86M 0.28% 97
2018
Q2
$8.24M Buy
195,185
+2,128
+1% +$96.1K 0.64% 28
2018
Q1
$9.12M Buy
193,057
+73,134
+61% +$3.51M 0.8% 17
2017
Q4
$5.5M Buy
119,923
+6,720
+6% +$300K 0.49% 51
2017
Q3
$4.94M Buy
113,203
+1,850
+2% +$80.1K 0.49% 50
2017
Q2
$4.55M Buy
111,353
+2,207
+2% +$89.5K 0.47% 55
2017
Q1
$4.37M Sell
109,146
-11,288
-9% -$436K 0.45% 55
2016
Q4
$4.31M Sell
120,434
-7,021
-6% -$257K 0.57% 41
2016
Q3
$4.8M Buy
127,455
+122,108
+2,284% +$4.55M 0.65% 35
2016
Q2
$189K Buy
5,347
+1,373
+35% +$46.9K 0.03% 458
2016
Q1
$137K Buy
+3,974
New +$125K 0.02% 511

Other funds holding VWO

Geneos Wealth Management's VWO Position: Q1 2026 in Review

Geneos Wealth Management increased its Vanguard FTSE Emerging Markets ETF (VWO) stake by 22% in Q1 2026, buying an estimated $2.09M and bringing the position to 203,555 shares worth $11M. The position accounts for 0.26% of the portfolio, ranked #89.

Geneos Wealth Management first reported a position in VWO in Q1 2016 and has held it in 41 quarters since. The position peaked at $24.4M in Q1 2025. 2,536 funds tracked by Wall St. Rank hold VWO as of Q1 2026.

  • Geneos Wealth Management held 203,555 shares of Vanguard FTSE Emerging Markets ETF worth $11M as of Q1 2026.
  • Geneos Wealth Management bought 37,229 Vanguard FTSE Emerging Markets ETF shares in Q1 2026, an estimated $2.09M.
  • Vanguard FTSE Emerging Markets ETF made up 0.26% of Geneos Wealth Management's portfolio in Q1 2026, its #89 holding.
  • Geneos Wealth Management first reported a position in Vanguard FTSE Emerging Markets ETF in Q1 2016 and has held it in 41 quarters since.
  • Geneos Wealth Management's Vanguard FTSE Emerging Markets ETF position peaked at $24.4M in Q1 2025.
  • 2,536 funds tracked by Wall St. Rank held Vanguard FTSE Emerging Markets ETF as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.